Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STP705 in Post-Keloidectomy Keloid Recurrence
NCT04844840Phase 2Completed
- Sponsor
- Sirnaomics
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Nanoparticles, Conjugated siRNA, Chemically Modified siRNA
- Countries
- 1
01
Overview
A Phase 2 trial of sirna-tgf-b1 + sirna-cox-2 in keloid, sponsored by Sirnaomics. Started Apr 2021; status: completed.
02
Drugs
sirna-tgf-b1 + sirna-cox-2
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04844840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04844840.